You are here: Industry Insights > COVID-19

News List

Alcohol Use Down, Nicotine Use Up for Teens During COVID-19 Pandemic drugs
August 25, 2021
During the first six months of the COVID-19 pandemic, youth in early adolescence had a reduced use of alcohol and an increased use of nicotine and misuse of prescription drugs, according to a study published in the September issue of the Journal.
More Than 10 Percent of Adults Missed Health Care in Spring 2021 drugs
August 25, 2021
Eleven percent of nonelderly adults and 9.2 percent of parents (on behalf of their children) report delaying or forgoing health care in the past 30 days due to concerns about coronavirus exposure, according to two reports published by the Urban Institute.
U.S. data show rising 'breakthrough' infections among fully vaccinated firstwordpharma
August 25, 2021
US officials reported on Tuesday that some 25% of COVID-19 infections among residents in Los Angeles County occurred in fully vaccinated residents from May through July 25, as reported by the National Post.
Pfizer CEO says COVID-19 vaccine-resistant variant likely to emerge firstwordpharma
August 25, 2021
Pfizer CEO Albert Bourla said the company believes a COVID-19 vaccine-resistant variant will likely one day emerge, but it has a system in place to turn around a variant-specific vaccine within some three months, Fox News reported.
New study to test third COVID-19 vaccine for people with weakened immune systems firstwordpharma
August 25, 2021
The government-funded study follows the results of the OCTAVE trial showing that 89% of people who are immunocompromised or immunosuppressed generate antibodies, and 60% generate a strong antibody response after two doses
FSD Pharma Announces Termination of FSD-201 Phase 2 Clinical Trial firstwordpharma
August 25, 2021
FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the "Company" or "FSD") announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide ("PEA"), or FSD-201, for use in treating COVID-19.
Disposable Gloves Market in Europe: COVID-19 Focused Report | Evolving Opportunities with Cardinal Health Inc. and Dynarex Corp. | Technavio prnewswire
August 25, 2021
The global disposable gloves market in Europe is expected to grow by USD 927.40 million, according to Technavio. This marks a significant market slowdown compared to the 2020 growth estimates due to the impact of the COVID-19 pandemic .
Medivolve Announces New COVID-19 Testing Mobile Vans Expanding On-Site Testing Opportunities to Schools, Workplaces, and Events prnewswire
August 25, 2021
Medivolve, Inc. ("Medivolve" or the "Company") (NEO: MEDV) (OTC: COPRF) (FRA: 4NC) today announced it will launch its first two mobile COVID-19 testing vans servicing Las Vegas, Nevada and surrounding areas.
Sterilization Services Market to Garner US$ 4,717.56 Million, Globally, by 2028 at 6.6% CAGR- COVID-19 Impact Analysis by The Insight Partners prnewswire
August 25, 2021
According to new research study on "Sterilization Services Market to 2028 – Global Analysis and Forecast – by Method, Service Type, Mode of Delivery, and End User," the market is projected to reach US$ 4,717.56 million by 2028 from US$ 3,023.50 million.
Sports Mouthguard Market Worth US$ 4,958.90 Million, Globally, by 2028 at 10.8% CAGR - COVID-19 Impact Analysis by The Insight Partners prnewswire
August 25, 2021
According to new research study on "Sports Mouthguard Market to 2028 – Global Analysis and Forecast – by Product, Distribution Channel, and Geography," the sports mouthguard market is projected to reach US$ 4,958.90 million by 2028.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page